Brokers Set Expectations for IONS Q1 Earnings
William Blair issued their Q1 2026 earnings per share (EPS) estimates for Ionis Pharmaceuticals in a report released on Wednesday, February 19th. William Blair analyst M. Minter forecasts that the ...
BMO Capital Markets Upgrades Century Aluminum (NASDAQ:CENX) to “Outperform”
BMO Capital Markets upgraded shares of Century Aluminum (NASDAQ:CENX – Free Report) from a market perform rating to an outperform rating in a report issued on Monday, Marketbeat Ratings reports. They ...
Hosted on MSN15h
BMO Capital Upgrades Block (XYZ)
Fintel reports that on February 24, 2025, BMO Capital upgraded their outlook for Block (NYSE:XYZ) from Market Perform to ...
‘Smaller cap’ growth stocks at a reasonable price that are best position to outperform – BMO
BMO Capital Markets recommend investors to focus on smaller caps within growth stocks (NYSEARCA:SPYG), (NYSEARCA:VOOG), ...
Ryerson price target raised to $25 from $23 at BMO Capital
BMO Capital raised the firm’s price target on Ryerson (RYI) to $25 from $23 and keeps a Market Perform rating on the shares. The company ...
Builders FirstSource price target lowered to $168 from $175 at BMO Capital
BMO Capital analyst Ketan Mamtora lowered the firm’s price target on Builders FirstSource (BLDR) to $168 from $175 and keeps a Market Perform ...
Block upgraded to Outperform at BMO after Q4 selloff creates attractive entry point
BMO Capital Markets upgraded Block (XYZ) to Outperform from Market Perform as analyst Rufus Hone sees the potential for ...
Fintel on MSN21h
BMO Capital Upgrades Century Aluminum (CENX)
Fintel reports that on February 24, 2025, BMO Capital upgraded their outlook for Century Aluminum (NasdaqGS:CENX) from Market ...